AstraZeneca PLC 6-K Report: Key Compliance & Governance Insights (Nov 2025)

Here are the key insights and information extracted from the provided section of the financial report:

1. Filing Information:

• Form Type: 6-K
• Commission File Number: 001-11960
• Filing Date: November 3, 2025

2. Company Details:

• Company Name: AstraZeneca PLC
• Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom

3. Annual Reports:

• The registrant indicates it files annual reports under Form 20-F.

4. Regulatory Compliance:

• The report indicates that the information is being furnished to the SEC pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

5. Exhibit Information:

• Exhibit No.: 99.1
• Description: Articles of Association adopted by special resolution passed on November 3, 2025.

6. Signatures:

• Authorized Signatory: Matthew Bowden
• Title: Company Secretary
• Date of Signature: November 3, 2025

This summary encapsulates the essential details from the 6-K filing, highlighting the company's compliance, governance details, and significant resolutions adopted.